|
|||||
|
|
Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for HER2 gene amplification by fluorescence in‐situ hybridization |
|
| Authors: | Gillian C Bethune Daniel Veldhuijzen van Zanten Rebecca F MacIntosh Daniel Rayson Tallal Younis Kara Thompson Penny J Barnes |
| Affiliation: | 1. Department of Pathology and Laboratory Medicine, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada;2. Division of Medical Oncology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada;3. Department of Medicine, Research Methods Unit, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada |
| Abstract: | |
| Keywords: | breast cancer equivocal category guidelines HER2 testing |